The sports world was blindsided with unfortunate news on Sunday when Houston Texans rookie receiver John Metchie announced his Acute Promyelocytic Leukemia diagnosis.
The No. 44 overall pick from the 2022 NFL draft will almost certainly miss his rookie campaign. Although safety Andre Hal was able to return to the playing field the same year he was diagnosed with Hodgkin’s Lymphoma, Acute Promyelocytic Leukemia requires aggressive treatment.
Aggressive treatment isn’t a negative; sometimes it can relate to how treatable a cancer is. For example, Burkitt’s Lymphoma Type-B, the fastest growing cancer on the books, is very treatable with a 90% survival rate after 10 years.
